Intimidate
发表于 2025-3-21 18:32:08
书目名称Antibodies影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0158460<br><br> <br><br>书目名称Antibodies影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0158460<br><br> <br><br>书目名称Antibodies网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0158460<br><br> <br><br>书目名称Antibodies网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0158460<br><br> <br><br>书目名称Antibodies被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0158460<br><br> <br><br>书目名称Antibodies被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0158460<br><br> <br><br>书目名称Antibodies年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0158460<br><br> <br><br>书目名称Antibodies年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0158460<br><br> <br><br>书目名称Antibodies读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0158460<br><br> <br><br>书目名称Antibodies读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0158460<br><br> <br><br>
electrolyte
发表于 2025-3-21 21:37:19
http://reply.papertrans.cn/16/1585/158460/158460_2.png
Hdl348
发表于 2025-3-22 01:58:49
Intrabodies: Development and Application in Functional Genomics and Therapy,is to interfere with their expression (.). Approaches such as gene knockout, antisense oligonucleotide or RNA interference (RNAi) are currently used to study gene and protein function and to validate candidate drug targets by analysing the effects of their deletion. One limitation of all these techn
上坡
发表于 2025-3-22 07:29:26
Expression of Recombinant Antibodies by Tumour Cells: On Road to Anti-Tumour Therapy, represent exciting tools for the targeted delivery of drugs, enzymes, and toxins at the site of the tumours. In addition, antibody-based radio-immunotherapy (RIT) should make it possible to circumvent the limitation of the treatment of solid tumours with antibodies due to the weak penetration of in
Anthrp
发表于 2025-3-22 09:48:18
Regine Witkowski,Falko H. Herrmann genetic engineering has allowed the conversion of existing mouse monoclonal antibodies into chimeric mouse-human antibodies, and humanised molecules where only the complementarity-determining regions (CDR) are of murine origin (.). To date, 13 therapeutic antibodies have obtained regulatory approva
流浪
发表于 2025-3-22 13:29:27
http://reply.papertrans.cn/16/1585/158460/158460_6.png
Mutter
发表于 2025-3-22 20:23:46
http://reply.papertrans.cn/16/1585/158460/158460_7.png
intuition
发表于 2025-3-22 22:53:12
http://reply.papertrans.cn/16/1585/158460/158460_8.png
minion
发表于 2025-3-23 04:20:42
http://reply.papertrans.cn/16/1585/158460/158460_9.png
态度暖昧
发表于 2025-3-23 08:47:39
http://reply.papertrans.cn/16/1585/158460/158460_10.png